The Parkville Cancer Clinical Trials Unit (PCCTU) is the largest clinical trials unit in Australia, with over 120 research staff working across 10 multidisciplinary clinical trials teams to provide research support for patients enrolled in trials across Peter Mac, Royal Melbourne Hospital, and the Royal Women’s hospital. This unit is growing exponentially with the rise of immunotherapies and other novel treatments. It is the unit's priority to ensure that care provided to participants on trial remains of high quality during this time of rapid growth. This Expect Exploration Patient Experience Communication Clinical Drug' study was therefore conducted to help the PCCTU review current patient care and communication practices to understand key areas of strength and opportunities for improvement. Outputs of this work will guide ongoing unit strategy development, and consumer engagement projects.
Aim
Conducted within Health Service Research, the aim of EXPECT is to:
- explore patient experience and perspectives of clinical drug trials, particularly the communication with the PCCTU team
- describe communication strategies currently being employed by PCCTU staff with both patients and internal stakeholders
- evaluate these strategies across key domains of health system performance: effectiveness, appropriateness, efficiency, and quality
Sponsor
-
Peter MacCallum Cancer Centre
Funding
Principal investigator
Ms Amelia Hyatt
-
Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Project team
-
Project Lead: Rowan Forbes Shepherd
-
Research Support: Ashleigh Bradford
Project status
-
Completed
Contact details
Ms Amelia Hyatt
-
Phone: (03) 8559 7837
-
Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.